Jump to content

Wikipedia:Articles for deletion/Dan Vahdat

From Wikipedia, the free encyclopedia
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was redirect to Medopad. MBisanz talk 00:02, 19 May 2016 (UTC)[reply]

Dan Vahdat (edit | talk | history | protect | delete | links | watch | logs | views) – (View log · Stats)
(Find sources: Google (books · news · scholar · free images · WP refs· FENS · JSTOR · TWL)

The subject's company, Medopad, appears to be notable, but the sources here are about that company and only mention Vahdat in passing, not in significant detail. I have been unable to find sources about him, so I think this fails our notability requirements. Cordless Larry (talk) 17:10, 30 April 2016 (UTC)[reply]

Note: This debate has been included in the list of People-related deletion discussions. NewYorkActuary (talk) 02:02, 1 May 2016 (UTC)[reply]
Note: This debate has been included in the list of Businesspeople-related deletion discussions. NewYorkActuary (talk) 02:02, 1 May 2016 (UTC)[reply]
  • Delete and I would've initially suggested redirecting to the company itself but that's unlikely any better as it's vulnerable to starting again (I'm willing to suggest Redirect but it has to be protected) and there's simply nothing to convince keeping these risks. Delete as there's nothing for independent notability. SwisterTwister talk 04:43, 1 May 2016 (UTC)[reply]
  • The article should stay He is co-founder and largest shareholder of a very successful company with market cap of $100M within a challenging space of healthcare. His company and both co-founders are not into creating too much of publicity, please feel free to amend the article as you see fit --Mhdv2011 (talk) 10:25, 1 May 2016 (UTC)Mhdv2011 (talkcontribs) has made few or no other edits outside this topic. [reply]
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks,  Sandstein  06:26, 8 May 2016 (UTC)[reply]
  • Merge/redirect to Medopad. The reliable sources in the article verify basic biographical details about him but do not cover him in significant detail as required by Wikipedia:Notability#General notability guideline. I recommend discussing him at Medopad, the company he founded, because the sources discuss him in the context of the company.

    A redirect (with the history under the redirect) is preferable so the redirect can be easily undone if reliable sources in the future discuss him in detail. SwisterTwister's concern that the redirect would be undone without new information surfacing can be handled by fully protecting the redirect if that issue arises.

    Cunard (talk) 06:36, 8 May 2016 (UTC)[reply]

Changed my !vote above. North America1000 22:26, 9 May 2016 (UTC)[reply]
  • Delete I was also going to swing to merge but after examining the sourcing more closely this in the Telegraph is the only reliable source which mentions him and only states his name. The economist and new scientist don't even mention him and which university he attended is sourced to a paper he was an author of - verifiable yes, but that's not the way to source biographical content. I'd be swung if some reliably sourced content could be identified. SmartSE (talk) 21:54, 9 May 2016 (UTC)[reply]
  • Delete No significant reliable references about him specifically. Delete or merge into article on company. — Preceding unsigned comment added by RockyMtChai (talkcontribs) 20:10, 13 May 2016 (UTC)[reply]
  • Delete Fails WP:GNG by a mile. I don't think a redirect is needed here either. Google news gives a total of 7 results on searching for the subject's name of which there are hardly any independent sources. I doubt people will search for him. --Lemongirl942 (talk) 09:52, 18 May 2016 (UTC)[reply]
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.